Comments
Dr Reddy’s Laboratories Ltd has launched Pemetrexed for Injection, the generic equivalent of Alimta (pemetrexed for injection) in the US market, approved by the US Food and Drug Administration (USFDA).
The Alimta brand and generic had US sales of approximately $1,239 million for the most recent twelve months ending in March 2022 according to IQVIA Health, the Hyderabad-based company said in a release on Friday.
Dr Reddy’s Pemetrexed for Injection, is supplied in 100 mg and 500 mg single-dose vials. It is generally initiated for certain types of cancer.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.